Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Clinical trial NCT06405685 · UNKNOWN
Trial details
- NCT number
- NCT06405685
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-27
- Primary completion
- 2025-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.